Wells Fargo & Company (BMV:WFC)

Verve Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,739,637	4,873,106	3,021,918	3,068,996	3,921,898	2,482,900
Market Cap Growth	29.99%	61.26%	-1.53%	-21.75%	57.96%	-42.15%
Last Close Price	1482.00	1450.10	788.10	752.36	897.73	540.62
PE Ratio	12.90	12.57	9.94	12.53	9.19	69.86
PS Ratio	3.24	3.00	2.32	2.16	2.30	2.07
PB Ratio	1.37	1.29	0.95	0.86	1.01	0.67
P/OCF Ratio	-	77.06	4.43	5.82	-	60.84
Debt / Equity Ratio	2.06	1.67	1.71	1.38	1.10	1.58
Return on Equity (ROE)	11.50%	10.84%	10.30%	7.19%	12.67%	1.96%
Return on Assets (ROA)	1.06%	1.03%	1.00%	0.70%	1.22%	0.19%
Earnings Yield	7.75%	8.43%	10.71%	8.69%	11.56%	2.71%
Dividend Yield	2.13%	2.15%	2.79%	2.85%	1.37%	4.49%
Payout Ratio	28.77%	31.60%	30.98%	38.70%	16.41%	181.88%
Buyback Yield / Dilution	7.29%	6.79%	3.04%	6.33%	0.92%	6.58%
Total Shareholder Return	9.33%	8.95%	5.83%	9.18%	2.29%	11.07%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.